In 2001, a Mumbai-based pharmaceutical company named Cipla did something that shook the world.HIV/AIDS was devastating Sub-Saharan Africa, killing millions, while the branded antiretroviral cocktail needed to survive cost up to US$12,000 per patient per year, a price that placed…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.